MTOR and epilepsy: Identification of a pathogenic GATOR1 variant can have important clinical implications: It may encourage further brain imaging to look for subtle dysplasias, raise awareness of important prognostic information such as the possible increased risk of SUDEP, suggest favourable epilepsy surgery outcomes, or highlight potential gene-driven future therapies such as mTOR pathway inhibitors [49] (see section on Gene-driven therapies for adults with monogenic epilepsies).